Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Safety Pilotstudy of RAltegravir and Atazanavir in a Once DAily Dose Regimen in HIV-1 Infected Patients (PRADA)

NCT00943540 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00943540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00943540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Safety Pilotstudy of RAltegravir and Atazanavir in a Once DAily Dose Regimen in HIV-1 Infected Patients (PRADA)
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
January 31, 2011
Enrollment
20 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, hiv infections